Skip to Main Content

Paper Details

Favorable pharmacokinetic and pharmacodynamic properties of gilteritinib in cerebrospinal fluid: a potential effective treatment in relapsing meningeal acute myeloid leukemia <i>FLT3</i>-ITD patients.
Haematologica
2
2023

Datasets

Release 1.2